CLS Holdings: Disposal, refinancing will 'impact' 2026 earnings

Celestica (CLS) faces near-term earnings pressures in 2026 amid ongoing institutional selling and strategic adjustments. Over the past six days, the stock has declined 13.4%, with a $4.6 billion drop in market capitalization, driven by profit-taking from institutional investors and significant insider selling over the prior three months. Despite this, the company reported strong Q4 2025 results, including a 44% year-over-year revenue increase to $3.65 billion and adjusted EPS of $1.89, leading to an upwardly revised 2026 revenue forecast of $17 billion.

The stock's recent volatility reflects broader valuation concerns, as CLS trades at a forward price-to-sales ratio of 2.19, above the industry average of 0.98. Analysts note that while Celestica's diversified portfolio—spanning data center infrastructure, aerospace/defense, and medical devices—enhances resilience, its high valuation and recent selling pressures could weigh on investor sentiment. BofA Securities recently initiated coverage with a "Buy" rating and $400 price target, citing growth potential in AI-driven data center upgrades and custom ASIC servers.

Celestica's financial performance remains robust, with FY2024 revenues reaching $9.6 billion and operating income of $618.7 million. However, the combination of institutional disposals, elevated valuation multiples, and strategic refinancing considerations may create near-term headwinds for earnings stability in 2026. Investors are advised to monitor the company's ability to balance growth initiatives with capital structure optimization amid market volatility.